Phil Baran’s group has recently
disclosed a de novo synthetic
approach for construction of the tetracyclic carbogenic steroid framework.
Their methodology features (arguably underutilized) quinone diazide
functionality as a latent cyclohexadienone carbene that readily undergoes
intramolecular olefin cyclopropanation to close the steroid B-ring. The authors
note that this unique carbene renders a phenol electrophilic at its normally
nucleophilic para position. The
quinone diazide cyclopropanation reaction exhibits quite broad substrate scope
in an intermolecular sense as well.
The advanced triazene intermediate (5) was designed
by the Scripps team to serve as the masked quinone diazide that would, in the
key synthetic operation (conversion of 6 à
7), undergo B-ring annulation. The synthesis of intermediate 5 involves a
standard Sonogashira coupling to introduce the two carbon atoms of the
requisite tether, followed by reduction of the nitro group. The resultant
aniline 2 is then diazotized and trapped with diisopropylamine to generate the
triazene functionality. The two-carbon tether is next elaborated to a vinyl
cuprate species which engages the bicyclic enone 4 in a conjugate addition reaction.
Preparation of the racemic steroidal C/D substructure 4 required six non-trivial
synthetic operations starting from 2-methylcyclopentenone. Installation of an
exocyclic olefin onto 5 is then required for the critical steroid annulation
step. This is achieved by treatment of the silyl enol ether 5 with the well-known
one-carbon electrophile, Eschenmoser’s salt. The critical rhodium-catalyzed
cyclopropanation operation proceeds through the intermediacy of the transiently generated
carbenoid shown above in the bracketed [TS-I]. The polycyclic steroid
derivative 7 is used in crude form in a subsequent carbon-carbon bond
fragmentation step (vida infra).
As one would expect, cyclopropane ring-opening
by nucleophilic chloride ion leads to cleavage of the C10-C19 bond, furnishing
the dione 8 in acceptable yield over the previous five steps. The authors noted
that much time and effort was invested in unsuccessful attempts to break the
C9-C19 bond. A fragmentation of this nature would provide access to a
synthetically useful prednisone-type carbocyclic connectivity. Unfortunately, in
the case of substrate 7, the A-ring dienone acts as an efficient electron-sink
and concomitant A-ring aromatization provides a strong thermodynamic driving
force for cleavage of C10-C19. Alternate reductive conditions were developed to
break the C9-C10 bond, expanding ring B to a seven-membered system reminiscent
of the cortistatins. The Baran route to prepare the dione 8 should be considered the
successful execution of a conceptually interesting retrosynthetic hypothesis
for steroid synthesis. However, in terms of practicality, their protocol falls
a bit short. The route requires a total of 18 synthetic operations (longest
linear sequence of 13), beginning from a relatively costly trisubstituted
nitrophenol (1). Moreover, the chemistry produces a racemic 11-oxo-estrone variant bearing a chloromethyl substituent
at C9. This specific molecular architecture is non-naturally occurring and
possesses (to my knowledge) no known pharmacologic or therapeutic medicinal
value.
On the contrary, novel methods for
direct halogenation of the steroid C9 position offer tremendous value due to
the demonstrated anti-inflammatory bioactivity of the 9-halo-corticosteroid series
(e.g. fludrocortisone). Assuming that a 9-hydroxymethyl derivative of Baran’s
advanced intermediate 8 could be accessed via cyclopropane cleavage with an O-nucleophile, a subsequent
base-mediated retro-aldol process would afford an enolate (Int-I shown above)
that could be trapped at C9 with an electrophilic source of fluorine. A proton
quench of the same enolate, followed by equilibration to the thermodynamically
favored natural estrone configuration would also be of interest.
A related methodology for steroid total
synthesis was recently reported by Wenjun Tang’s group. They have developed a
new P-chiral biaryl monophosphine
ligand (L*) that, in combination with a palladium catalyst, mediates the
enantioselective dearomative cyclization of phenols that are tethered to enol
triflates or aryl halides. For example, cyclization of the enol triflate 13, following
initial oxidative addition, proceeds through the intermediacy of TS-I, depicted
above in brackets. Nucleophilic substitution at the 4-position of the phenol
moiety, followed by reductive elimination, then closes the steroid B-ring and
furnishes 14 in a highly stereocontrolled fashion. Tang’s asymmetric synthesis
of 14 (or 15, using the opposite antipode of the phosphine) proceeds in only
four steps (!!!) starting from the readily available and optically active Hajos-Parrish
ketone. This level of efficiency and practicality could potentially become
competitive with analogous microbial biofermentation processes, particularly if
the unique P-chiral catalyst were to
become commercially available.
Maitake Extract , made in the USA. It is a great source of protein, carbohydrates, dietary fiber, vitamin D2 and vitamin K, potassium, sodium, calcium, and magnesium. It is a food supplement for daily use, Maitake mushrooms are effective in the treatment of cancer, hepatitis B and to improve immunity. Maitake is also used to treat hyperglycemia and control fat and cholesterol levels in the blood. Maitake also has antihypertensive and anti-inflammatory properties and is completely safe with minimal toxicity.
ReplyDelete